Acrivon Therapeutics (ACRV) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 13, 2025, to be held virtually for stockholders of record as of April 21, 2025.

• Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request by June 3, 2025.

Voting matters and shareholder proposals

• Stockholders will vote on the election of three Class III director nominees: Peter Blume-Jensen, Derek DiRocco, and Santhosh Palani.

• Proposal to ratify PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.

• Other business may be transacted as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting FOR all director nominees and FOR the ratification of the auditor.